摘要
目的针对当前血清淀粉样蛋白A对皮肤病诊断的临床意义开展深入分析,判断血清淀粉样蛋白A检验在临床上的价值.方法选取我院2019年10月1日-2021年9月30日收治的皮肤病患者496例为研究对象设置为研究组,随机选取同期100例健康体检者为研究对象设置为参照组.两组研究对象同时进行免疫散射比浊法测定血清淀粉样蛋白A.结果参照组的血清淀粉样蛋白A含量水平低于研究组,组间差异具有统计学意义(P<0.05).结论检验者行血清淀粉样蛋白A检验可以通过其含量水平反馈其是否存在皮肤病,对皮肤病患者疾病诊断提供了指导性意见.
Objective To carry out an in-depth analysis of the current clinical significance of the serum amyloid A in dermatological diagnosis,and to judge the clinical value of the serum amyloid A test.Methods 496 dermatological patients admitted from October 1,2019 to September 30,2021 were selected as the study group,and 100 patients were randomly selected as the subjects as the reference group.Both subjects simultaneously performed immune scattering ratio turbidimetry to determine serum amyloid A.Results The serum amyloid A content level in the reference group was lower than that in the study group,which was statistically significant(P<0.05).Conclusion The serum amyloid protein A test can feedback the presence of skin disease through its content level,which provides guidance for the disease diagnosis of dermatology patients.
作者
杨雪
YANG Xue(PKUCare CNOOC Hospital,Tianjin 300450,China)
出处
《医学信息》
2022年第S01期109-110,共2页
Journal of Medical Information
